1 - Dietary Sodium Reduction AdviceOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients who received formal advice on dietary sodium restriction by the renal dietician within the past 90 days.
Type: Process
2 - Utilization of High Ultrafiltration Rate for Fluid RemovalOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients who did not receive an ultrafiltration (UF) rate greater than or equal to 15 mg/kg/hr in the reporting month.
Type: Process
3 - Utilization of Dialysis Duration of Four Hours or Longer for Patients New to DialysisOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients new to hemodialysis (within the first 90 days since initiation of hemodialysis) whose delivered dialysis session length was at least 240 minutes.
Type: Process
4 - Restriction of Dialysate SodiumOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of hemodialysis patients who were prescribed a dialysate sodium concentration less than or equal to 138 mEq/L in the reporting month.
Type: Process
5 - Sodium Profiling Practice for HemodialysisOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of hemodialysis patients who were not prescribed sodium profiling in the reporting month.
Type: Process
6 - VA-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of hemodialysis vascular access-related infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
7 - Clinically Confirmed Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of clinically confirmed infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
8 - Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of bacteremia with IV antibiotic therapy, among adult chronic HD patients
Type: Process
9 - Graft-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
10 - Fistula-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
11 - Catheter-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related infection with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
12 - Graft-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous graft for hemodialysis access
Type: Process
13 - Fistula-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using an arteriovenous fistula for hemodialysis access
Type: Process
14 - Catheter-Related Bacteremia (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate for access-related bacteremia with IV antibiotic therapy, among adult chronic HD patients using a catheter for hemodialysis access
Type: Process
15 - Catheter-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis catheter-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
16 - Graft-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous graft-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
17 - Fistula-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis arteriovenous fistula-related infection among adult chronic HD patients with a HD access-related infection and prescribed IV antibiotics
Type: Process
18 - VA-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis access-related infection among adult chronic HD patients with a clinically confirmed infection and prescribed IV antibiotics
Type: Process
19 - Clinically Confirmed Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of clinically confirmed infection among HD patients prescribed IV antibiotics
Type: Process
20 - VA-Related Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients with a hemodialysis access-related infection and prescribed IV antibiotics
Type: Process
